Reports of long-lasting symptoms of COVID-19 are increasing, but little is known about the prevalence of risk factors or whether it is possible to predict a prolonged course at disease onset. Prolonged COVID is characterized on the basis of symptoms such as fatigue, headache, dyspnea, and anosmia present for weeks, with older age, high body mass index, and female sex being more susceptible. Accordingly, and in the absence of specific treatments, the present study seeks to establish a treatment protocol for Post-COVID syndrome through the application of the dietary supplement VIUSID, due to its anti-inflammatory and immunomodulatory effect, thus helping to reduce and/or control the symptoms of the syndrome.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Evaluation of the symptoms associated with post-COVID-19 syndrome.
Timeframe: 30 days
Evaluation of inflammation associated with Post-COVID-19 syndrome.
Timeframe: 30 days
Evaluation of oxidative stress associated with Post-COVID-19 syndrome
Timeframe: 30 days
Evaluation of pulmonar fibrosis associated with Post-COVID-19 syndrome
Timeframe: 30 days